$SRPT Sarepta Therapeutics, Inc. SRPT Company Overview
Stock Message Board http://investorshangout.com/search?q=SRPT&...mp;yt1=Go!
Last Updated: Tuesday, November 12, 2013 4:25:49 PM
Sarepta Therapeutics, Inc. SRPT Current Price and Quotes
Last Price 13.158
Previous Close 36.56 Open 16.18
Daily Range 16.70 - 12.35 52wk Range 55.61 - 23.46
Volume 38,407,676 Dividend N/A
Average Vol (3m) 1,951,728 Yield N/A
Sarepta Therapeutics, Inc. SRPT
Company Information
215 First Street
Suite 007
Cambridge, MA 02142
Website: http://www.antivirals.com
Phone: 857-242-3700
Email: avi@avibio.com
Sarepta Therapeutics, Inc. SRPT
Sarepta Therapeutics, Inc. SRPT
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000873303
Fiscal Year End 1/31
OTC Marketplace Not Available
Profile Data
SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Notes
Note = Domicile changed from Oregon to Delaware in June of 2013
Formerly=AVI BioPharma, Inc. until 7-2012
Formerly=AntiVirals, Inc. until 8-98
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Sarepta Therapeutics, Inc. SRPT
SRPT Security Details Other Company Securities
Share Structure
Market Value1 $1,391,071,741 a/o Nov 11, 2013
Shares Outstanding 33,527,880 a/o Jul 31, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.0001
Shareholders
Shareholders of Record Not Available
Security Notes
Capital Change=shs decreased by 1 for 6 split. Ex-date=07/12/2012.
Short Selling Data
Short Interest 10,287,182 (8.79%)
Nov 30, 2010
Significant Failures to Deliver No
Transfer Agent(s)
Sarepta Therapeutics, Inc. SRPT Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 37,329 46,990 29,420 17,585
Cost of Revenue - - - -
Gross Profit 37,329 46,990 29,420 17,585
Operating Expenses
Research and Development 52,402 66,862 35,972 24,396
Sales, General and Admin. 14,630 16,055 14,382 8,696
Non-Recurring Items - - - -
Other - - - -
Operating Income (29,703) (35,927) (20,934) (15,507)
Income From Continuing Operations
Add'l Income/Expense Items (91,584) 33,609 (11,243) (9,198)
Earnings Before Interest and Tax (121,287) (2,318) (32,177) (25,159)
Interest Expense - - - -
Earnings Before Tax (121,287) (2,318) (32,177) (25,159)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (121,287) (2,318) (32,177) (25,159)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (121,287) (2,318) (32,177) (25,159)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (121,287) (2,318) (32,177) (25,159)
Sarepta Therapeutics, Inc. SRPT Recent News
Nov 12, 2013 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sarepta Therapeutics, Inc.
Nov 12, 2013 SRPT, HOLX, QUIK and VNDA added to NASDAQ Active Stock Watch List at GSR
Nov 12, 2013 Sarepta Therapeutics Announces Third Quarter 2013 Financial Results and Recent Corporate Developments
Nov 11, 2013 Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver
Nov 11, 2013 Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc.
Oct 24, 2013 Sarepta Therapeutics to Announce Third Quarter 2013 Financial Results and Corporate Update on November 12, 2013
Oct 21, 2013 Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc.
Oct 17, 2013 Parent Project Muscular Dystrophy and Sarepta Therapeutics Join Forces on Genetic Testing Program for Patients With Duchenne Muscular Dystrophy
Oct 10, 2013 Sarepta Therapeutics to Host Webcast and Conference Call for the Duchenne Muscular Dystrophy Community on October 17, 2013
Oct 8, 2013 Critical Alerts For Coca-Cola, Biogen Idec, Hewlett-Packard, Yum! Brands, and Sarepta Therapeutics Released By InvestorsObserver
1
2
next >
SRPT Sarepta Therapeutics, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=SRPT&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/SRPT/quote
Stock Chart http://www.otcmarkets.com/stock/SRPT/chart
Company Info http://www.otcmarkets.com/stock/SRPT/company-info
Recent News http://www.otcmarkets.com/stock/SRPT/news
Financials http://www.otcmarkets.com/stock/SRPT/financials
Filings and Disclosure http://www.otcmarkets.com/stock/SRPT/filings
Short Sales http://www.otcmarkets.com/stock/SRPT/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/SRPT/insider-transactions
Research Reports http://www.otcmarkets.com/stock/SRPT/research
Summary http://finance.yahoo.com/q?s=SRPT
Historical Prices http://finance.yahoo.com/q/hp?s=SRPT+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=SRPT
Basic Chart http://finance.yahoo.com/q/bc?s=SRPT+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SRPT+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=SRPT+Headlines
Press Releases http://finance.yahoo.com/q/p?s=SRPT+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=SRPT+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=SRPT+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=SRPT+Industry
Major Holders http://finance.yahoo.com/q/mh?s=SRPT+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=SRPT+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=SRPT+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=SRPT
Balance Sheet http://finance.yahoo.com/q/bs?s=SRPT
Cash Flow http://finance.yahoo.com/q/cf?s=SRPT+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/SRPT
Market Watch http://www.marketwatch.com/investing/stock/SRPT
Bloomberg http://www.bloomberg.com/quote/SRPT:US
Morningstar http://quotes.morningstar.com/stock/s?t=SRPT
Bussinessweek http://investing.businessweek.com/research/st...icker=SRPT
Barchart http://www.barchart.com/quotes/stocks/SRPT
OTC Short Report http://otcshortreport.com/index.php?index=SRPT
Investopedia http://www.investopedia.com/markets/stocks/SRPT/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Stock Message Board http://investorshangout.com/search?q=SRPT&...mp;yt1=Go!
Last Updated: Tuesday, November 12, 2013 4:25:49 PM
Sarepta Therapeutics, Inc. SRPT Current Price and Quotes
Last Price 13.158
Previous Close 36.56 Open 16.18
Daily Range 16.70 - 12.35 52wk Range 55.61 - 23.46
Volume 38,407,676 Dividend N/A
Average Vol (3m) 1,951,728 Yield N/A
Sarepta Therapeutics, Inc. SRPT
Company Information
215 First Street
Suite 007
Cambridge, MA 02142
Website: http://www.antivirals.com
Phone: 857-242-3700
Email: avi@avibio.com
Sarepta Therapeutics, Inc. SRPT
Sarepta Therapeutics, Inc. SRPT
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000873303
Fiscal Year End 1/31
OTC Marketplace Not Available
Profile Data
SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Notes
Note = Domicile changed from Oregon to Delaware in June of 2013
Formerly=AVI BioPharma, Inc. until 7-2012
Formerly=AntiVirals, Inc. until 8-98
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Sarepta Therapeutics, Inc. SRPT
SRPT Security Details Other Company Securities
Share Structure
Market Value1 $1,391,071,741 a/o Nov 11, 2013
Shares Outstanding 33,527,880 a/o Jul 31, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.0001
Shareholders
Shareholders of Record Not Available
Security Notes
Capital Change=shs decreased by 1 for 6 split. Ex-date=07/12/2012.
Short Selling Data
Short Interest 10,287,182 (8.79%)
Nov 30, 2010
Significant Failures to Deliver No
Transfer Agent(s)
Sarepta Therapeutics, Inc. SRPT Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 37,329 46,990 29,420 17,585
Cost of Revenue - - - -
Gross Profit 37,329 46,990 29,420 17,585
Operating Expenses
Research and Development 52,402 66,862 35,972 24,396
Sales, General and Admin. 14,630 16,055 14,382 8,696
Non-Recurring Items - - - -
Other - - - -
Operating Income (29,703) (35,927) (20,934) (15,507)
Income From Continuing Operations
Add'l Income/Expense Items (91,584) 33,609 (11,243) (9,198)
Earnings Before Interest and Tax (121,287) (2,318) (32,177) (25,159)
Interest Expense - - - -
Earnings Before Tax (121,287) (2,318) (32,177) (25,159)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (121,287) (2,318) (32,177) (25,159)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (121,287) (2,318) (32,177) (25,159)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (121,287) (2,318) (32,177) (25,159)
Sarepta Therapeutics, Inc. SRPT Recent News
Nov 12, 2013 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sarepta Therapeutics, Inc.
Nov 12, 2013 SRPT, HOLX, QUIK and VNDA added to NASDAQ Active Stock Watch List at GSR
Nov 12, 2013 Sarepta Therapeutics Announces Third Quarter 2013 Financial Results and Recent Corporate Developments
Nov 11, 2013 Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver
Nov 11, 2013 Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc.
Oct 24, 2013 Sarepta Therapeutics to Announce Third Quarter 2013 Financial Results and Corporate Update on November 12, 2013
Oct 21, 2013 Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc.
Oct 17, 2013 Parent Project Muscular Dystrophy and Sarepta Therapeutics Join Forces on Genetic Testing Program for Patients With Duchenne Muscular Dystrophy
Oct 10, 2013 Sarepta Therapeutics to Host Webcast and Conference Call for the Duchenne Muscular Dystrophy Community on October 17, 2013
Oct 8, 2013 Critical Alerts For Coca-Cola, Biogen Idec, Hewlett-Packard, Yum! Brands, and Sarepta Therapeutics Released By InvestorsObserver
1
2
next >
SRPT Sarepta Therapeutics, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=SRPT&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/SRPT/quote
Stock Chart http://www.otcmarkets.com/stock/SRPT/chart
Company Info http://www.otcmarkets.com/stock/SRPT/company-info
Recent News http://www.otcmarkets.com/stock/SRPT/news
Financials http://www.otcmarkets.com/stock/SRPT/financials
Filings and Disclosure http://www.otcmarkets.com/stock/SRPT/filings
Short Sales http://www.otcmarkets.com/stock/SRPT/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/SRPT/insider-transactions
Research Reports http://www.otcmarkets.com/stock/SRPT/research
Summary http://finance.yahoo.com/q?s=SRPT
Historical Prices http://finance.yahoo.com/q/hp?s=SRPT+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=SRPT
Basic Chart http://finance.yahoo.com/q/bc?s=SRPT+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SRPT+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=SRPT+Headlines
Press Releases http://finance.yahoo.com/q/p?s=SRPT+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=SRPT+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=SRPT+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=SRPT+Industry
Major Holders http://finance.yahoo.com/q/mh?s=SRPT+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=SRPT+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=SRPT+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=SRPT
Balance Sheet http://finance.yahoo.com/q/bs?s=SRPT
Cash Flow http://finance.yahoo.com/q/cf?s=SRPT+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/SRPT
Market Watch http://www.marketwatch.com/investing/stock/SRPT
Bloomberg http://www.bloomberg.com/quote/SRPT:US
Morningstar http://quotes.morningstar.com/stock/s?t=SRPT
Bussinessweek http://investing.businessweek.com/research/st...icker=SRPT
Barchart http://www.barchart.com/quotes/stocks/SRPT
OTC Short Report http://otcshortreport.com/index.php?index=SRPT
Investopedia http://www.investopedia.com/markets/stocks/SRPT/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
